Company type
Provider of cancer molecular information solutions.Funding rounds
Series B USD 12,500,000
USD 12,500,000 ( )
ACT Genomics plans to use the proceeds to further boost the capacity to support the rapid growth and expansion in Japan, Taiwan, Singapore, Malaysia, Thailand, and Hong Kong. The new proceeds will also enable ACT Genomics to ramp up its commercial channel
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
CDIB Capital Management | Led the round. | ||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Hotung Group | Led the round. | ||
|
|
Eminent II VC | Follow-on investment. | ||
|
|
Hua Nan Venture Capital | Follow-on investment. | ||
|
|
President International Development Corp | Follow-on investment. | ||
|
UMC Capital | Follow-on investment. |
Investment activity status
Active investor